SAN FRANCISCO - The disease modifying antirheumatic drug (DMARD) leflunomide (Arava), approved for use in rheumatoid arthritis, may also be an effective therapy for recalcitrant psoriatic arthritis and psoriasis, according to two new studies.
The Weekly Roundup: February 18-23
ReV Up Your Vitiligo Treatment Strategies
Improving Representation of Skin of Color in Dermatology
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Cysteamine Isobionic-Amide Complex Demonstrates On Par Efficacy, Onset of Action in Melasma as Kligman's Formula
Hair and Skin Publications From Sub-Saharan Africa Are Steadily Increasing, Researchers Report
2 Commerce Drive Cranbury, NJ 08512